Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model

World Journal of Gastroenterology

Volumn 13, Issue 14, 2007, Pages 2113-2117

  Gu, Tao ^a   Li, Cai Xia ^a   Feng, Yan ^a   Wang, Qian ^a   Li, Chun Hai ^a   Li, Chuan Fu ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Gene therapy; Liver hepatocellular carcinoma; Trans arterial chemoembolization

Indexed keywords

ADENOVIRUS VECTOR; IODINATED POPPYSEED OIL; MITOMYCIN C; PROTEIN ANTIBODY; PROTEIN P53; SODIUM CHLORIDE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CHEMOEMBOLIZATION; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MUTANT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; TUMOR VOLUME; VIRAL GENE THERAPY;

EID: 34249004868     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i14.2113     Document Type: Article

References (21)

1. Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol 2002; 35: S130-S137
2. Tang ZY. Treatment of hepatocellular carcinoma. Digestion 1998; 59: 556-562
3. Alsowmely AM, Hodgson HJ. Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2002; 16: 1-15
4. Durand F, Belghiti J. Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 2002; 49: 47-52
5. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466-486
6. Denys AL, De Baere T, Kuoch V, Dupas B, Chevallier P, Madoff DC, Schnyder P, Doenz F. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol 2003; 13: 2346-2352
7. Lee JM, Lee YH, Kim YK, Kim SW, Kim SH, Han JK, Choi BI. Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver. Eur Radiol 2004; 14: 1303-1310
8. Buscarini E, Buscarini L. Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol 2004; 14: 31-37
9. Sturm JW, Keese MA, Bonninghoff RG, Wustner M, Post S. Locally ablative therapies of hepatocellular carcinoma. Onkologie 2001; 24 Suppl 5: 35-45
10. Achenbach T, Seifert JK, Pitton MB, Schunk K, Junginger T. Chemoembolization for primary liver cancer. Eur J Surg Oncol 2002; 28: 37-41
11. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J, Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739
12. Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, Neuhaus P, Felix R. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 2000; 214: 349-357
13. Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S319-S328
14. Chen GG, Merchant JL, Lai PB, Ho RL, Hu X, Okada M, Huang SF, Chui AK, Law DJ, Li YG, Lau WY, Li AK. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89. Am J Pathol 2003; 162: 1823-1829
15. Kouraklis G. Progress in cancer gene therapy. Acta Oncol 1999; 38: 675-683
16. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-810
17. Guan YS, Liu Y, Sun L, Li X, He Q. Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization. World J Gastroenterol 2005; 11: 3803-3805
18. Sze DY, Freeman SM, Slonim SM, Samuels SL, Andrews JC, Hicks M, Ahrar K, Gupta S, Reid TR. Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival. J Vasc Interv Radiol 2003; 14: 279-290
19. Carlsson G, Gullberg B, Hafstrom L. Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 1983; 105: 20-23
20. Ramirez LH, Zhao Z, Rougier P, Bognel C, Dzodic R, Vassal G, Ardouin P, Gouyette A, Munck JN. Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbits. Cancer Chemother Pharmacol 1996; 37: 371-376
21. Yoshida T, Sakon M, Umeshita K, Kanai T, Miyamoto A, Takeda T, Gotoh M, Nakamura H, Wakasa K, Monden M. Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study. J Clin Gastroenterol 2001; 32: 59-65